[1]JA Kim, EK Lee, SJ Park, et al. Novel anti-cancer role of naphthazarin in human gastric cancer cells[J]. Int J Oncol, 2012,40: 157-162.
[2]R Shi, W Li, X Zhang, et al. A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells[J]. Eur J Pharmacol, 2011,669: 38-44.
[3]林涛.胃癌MDR细胞特异性结合及耐药逆转短肽的筛选[D].西安:第四军医大学,2006,30-62.
[4]PW Gold, FK Goodwin, T Wehr, et al. Growth-hormone and prolactin response to levodopa in affective illnessP[J]. Lancet, 1976,2: 1308-1309.
[5]CJ Reist, PK Garg, KL Alston, et al. Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate[J]. Cancer Res, 1996,56: 4970-4977.
[6]J Castro, M Ribo, S Navarro, et al. A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation[J]. BMC Cancer, 2011,11: 9.
[7]X Hui, Y Han, S Liang, et al. Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC[J]. J Control Release, 2008,131: 86-93.
[8]I Dijkraaf, HJ Wester, Peptides, multimers and polymers[J]. Handb Exp Pharmacol, 2008, 61-92.
[9]L Tran, JW Baars, HJ Maessen, et al. A simple and safe method for 131I radiolabeling of rituximab for myeloablative high-dose radioimmunotherapy[J]. Cancer Biother Radiopharm, 2009,24:103-110.
[10]Z Liu, F Wang, X Chen.Integrin targeted delivery of radiotherapeutics[J]. Theranostics, 2011,1:201-210.
[11]AH Grossmann, WS Samowitz. Epidermal growth factor receptor pathway mutations and colorectal cancer therapy[J]. Arch Pathol Lab Med, 2011,135:1278-1282.
[12]许文静.胃癌多药耐药逆转短肽GMBP42的活性鉴定[J]. 现代肿瘤医学,2011,19(4):623-626.(编校:张志明)